To Evaluate the Efficacy of atomoxetine on Symptom Awareness and Cognitive Function during Repeated Hypoglycemia in Healthy Individuals

Trial Profile

To Evaluate the Efficacy of atomoxetine on Symptom Awareness and Cognitive Function during Repeated Hypoglycemia in Healthy Individuals

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2015

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus First in man; Therapeutic Use
  • Most Recent Events

    • 25 Aug 2015 New trial record
    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top